HCV-1b and DLBCL: DAAs during chemotherapy boost DFS

Access to the full content of this site is available only to registered healthcare professionals. Register to read more

Takeaway

  • HCV treatment with direct-acting antivirals (DAAs) during chemotherapy has a positive effect on remission of aggressive diffuse large B cell lymphomas (DLBCL).

Why this matters

  • HCV has been linked to non-Hodgkin lymphoma (NHL).
  • Whether HCV should be treated in patients wit...